Characterization of Neisseria gonorrhoeaeisolates detected in Switzerland (1998–2012): emergence of multidrug-resistant clones less susceptible to cephalosporins
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of Neisseria gonorrhoeaeisolates detected in Switzerland (1998–2012): emergence of multidrug-resistant clones less susceptible to cephalosporins
Authors
Keywords
Gonococcus, ST1407, MIC, Ceftriaxone, Cefixime, MDR, NG-MAST, PBP1, PBP2, Mosaic
Journal
BMC INFECTIOUS DISEASES
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-02-25
DOI
10.1186/1471-2334-14-106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Amino Acids Conferring High-Level Resistance to Expanded-Spectrum Cephalosporins in thepenAGene from Neisseria gonorrhoeae Strain H041
- (2013) Joshua Tomberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified Surveillance after Identification of the First Strain (H041) with High-Level Ceftriaxone Resistance
- (2013) Ken Shimuta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012
- (2013) Helen Kovari et al. BMC INFECTIOUS DISEASES
- Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010
- (2013) Irene Martin et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada
- (2013) Vanessa G. Allen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tracing subsequent dissemination of a cluster of gonococcal infections caused by an ST1407-related clone harbouring mosaic penA alleles in Taiwan
- (2013) C.-C. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure
- (2013) D. A. Lewis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011
- (2013) Catherine A Ison et al. LANCET INFECTIOUS DISEASES
- Prevalence and Molecular Epidemiological Typing of Penicillinase-Producing Neisseria gonorrhoeae and Their blaTEM-135 Gene Variants in Nanjing, China
- (2013) Shao-Chun Chen et al. SEXUALLY TRANSMITTED DISEASES
- Clonally Related Neisseria gonorrhoeae Isolates with Decreased Susceptibility to the Extended-Spectrum Cephalosporin Cefotaxime in Amsterdam, the Netherlands
- (2012) Raymond Heymans et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genome Sequencing of a Neisseria gonorrhoeae Isolate of a Successful International Clone with Decreased Susceptibility and Resistance to Extended-Spectrum Cephalosporins
- (2012) David Hess et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TaqMan Real-Time Quantitative PCR Assay for Detection of Fluoroquinolone-Resistant Neisseria gonorrhoeae
- (2012) LiHong Zhao et al. CURRENT MICROBIOLOGY
- Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea
- (2012) Magnus Unemo et al. Future Microbiology
- Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain
- (2012) J. Camara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan
- (2012) Satoshi Takahashi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Multiplex Bead Suspension Array for Screening Neisseria gonorrhoeae Antibiotic Resistance Genetic Determinants in Noncultured Clinical Samples
- (2012) Sergey Balashov et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Molecular Analyses of TEM Genes and Their Corresponding Penicillinase-Producing Neisseria gonorrhoeae Isolates in Bangkok, Thailand
- (2011) Shu-ichi Nakayama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone
- (2011) Makoto Ohnishi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment Failure
- (2011) Magnus Unemo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial resistance inNeisseria gonorrhoeaein the UK: surveillance and management
- (2011) Catherine A Ison et al. Expert Review of Anti-Infective Therapy
- High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes
- (2010) S. A. Chisholm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Analysis of Antimicrobial Resistance Mechanisms inNeisseria gonorrhoeaeIsolates from Ontario, Canada
- (2010) Vanessa G. Allen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of TEM-135 -Lactamase in Penicillinase-Producing Neisseria gonorrhoeae Strains in Japan
- (2010) M. Ohnishi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinically relevant mutations that cause derepression of theNeisseria gonorrhoeaeMtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance andin vivofitness
- (2008) Douglas M. Warner et al. MOLECULAR MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started